U.S. markets open in 2 hours 5 minutes

  • S&P Futures

    4,386.50
    -25.25 (-0.57%)
     

  • Dow Futures

    34,889.00
    -85.00 (-0.24%)
     

  • Nasdaq Futures

    14,892.50
    -145.25 (-0.97%)
     

  • Russell 2000 Futures

    2,226.90
    -10.60 (-0.47%)
     

  • Crude Oil

    73.43
    -0.19 (-0.26%)
     

  • Gold

    1,831.40
    -4.40 (-0.24%)
     

  • Silver

    25.56
    -0.23 (-0.88%)
     

  • EUR/USD

    1.1905
    +0.0008 (+0.07%)
     

  • 10-Yr Bond

    1.2690
    0.0000 (0.00%)
     

  • Vix

    18.84
    +0.53 (+2.89%)
     

  • GBP/USD

    1.3966
    +0.0008 (+0.06%)
     

  • USD/JPY

    109.6250
    +0.1640 (+0.15%)
     

  • BTC-USD

    38,881.55
    -1,337.20 (-3.32%)
     

  • CMC Crypto 200

    924.16
    -6.20 (-0.67%)
     

  • FTSE 100

    7,016.37
    -62.05 (-0.88%)
     

  • Nikkei 225

    27,283.59
    -498.83 (-1.80%)
     

Imara to Webcast Conference Call of Second Quarter 2021 Financial Results and Business Highlights

Imara, Inc.
·1 min read

BOSTON, July 30, 2021 (GLOBE NEWSWIRE) -- Imara Inc. (Nasdaq: IMRA), a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat patients suffering from rare inherited genetic disorders of hemoglobin, today announced that the company will host a conference call and live webcast on Friday, August 6, 2021, at 8:30 a.m. ET to discuss its financial results for the quarter ended June 30, 2021 and review recent business highlights.

A live webcast will be available under “Events and Presentations” in the Investors section of the company's website. The conference call can be accessed by dialing 1 (833) 519-1307 (U.S. domestic) or +1 (914) 800-3873 (international) and referring to conference ID 6499377. A replay of the webcast will be archived on the Imara website following the presentation.

About Imara
Imara Inc. is a clinical-stage biotechnology company dedicated to developing and commercializing novel therapeutics to treat patients suffering from rare inherited genetic disorders of hemoglobin. Imara is currently advancing IMR-687, a highly selective, potent small molecule inhibitor of PDE9 that is an oral, once-a-day, potentially disease-modifying treatment for sickle cell disease and beta-thalassemia. IMR-687 is being designed to have a multimodal mechanism of action that acts on red blood cells, white blood cells, adhesion mediators and other cell types. For more information, please visit www.imaratx.com.

Media Contact:
Marin Bergman
Ten Bridge Communications
818-516-2746
marin@tenbridgecommunications.com

Investor Contact:
Michael Gray
617-835-4061
mgray@imaratx.com


Recommended Stories

  • Why Amazon shares fell after Q2 earnings results

    Daniel Newman, Futurum Research Principal Analyst joins Yahoo Finance to break down Amazon's Q2 earnings results. 

  • Is Tilray Stock a Buy After Its Surprising Q4 Profit?

    Tilray shareholders are on cloud nine after the company announced unexpectedly positive results. Tilray delivered a big surprise with its first quarterly update after merging with Aphria -- a profit. Tilray posted adjusted EBITDA of $12.3 million in Q4, up 285% year over year.

  • Nikola electric-truck prototypes were powered by hidden wall sockets, towed into position and rolled down hills, prosecutors say

    Prosecutors said the prototypes didn’t function and were Frankenstein monsters cobbled together from parts from other vehicles.

  • Why Citrix Systems Stock Just Crashed

    Shares of Citrix Systems (NASDAQ: CTXS) plummeted 14.3% through 1:15 p.m. EDT today, after the software-as-a-service (SaaS) provider announced what even it called "mixed" results in its fiscal Q2 2021 financial report. On the one hand, Citrix beat earnings with a report of $1.24 per share (pro forma) earned, where Wall Street had been looking for only $1.19. Citrix's $1.24-per-share pro forma profit vastly overstated the company's profits as calculated according to generally accepted accounting principles (GAAP), which amounted to only $0.50 per share, a year-over-year decline of 44%.

  • Cathie Wood Sold Her Chinese Stocks. Should You?

    Investing in China has always come with a special set of risks, but for most of modern history, investors have been able to ignore those as Chinese growth stocks have delivered. Suddenly, those risks, which include investing in a country where American standards of rule of law and investor protections are non-existent, are back in focus. The Chinese Communist Party wiped out nearly all the value in the for-profit education sector in that country when it said that tutoring companies like New Oriental Education Group and TAL Education Group would be barred from making profits, and that they would have to register as non-profit enterprises.

  • Caterpillar Earnings Beat Expectations. Its Stock Is Down.

    (CAT) stock is slipping after the machinery manufacturer reported earnings that topped analyst forecasts. Caterpillar (CAT) reported a profit of $2.60, beating estimates for $2.41, on sales of $12.89, beating forecasts for $12.51 billion. Caterpillar stock was off 0.5% at $211.50 at 7:01 a.m. in premarket trading.

  • Apple Sells $6.5 Billion of Bonds, Adding Cash for Buybacks

    (Bloomberg) -- Apple Inc. tapped the U.S. investment-grade bond market on Thursday with a $6.5 billion sale in four parts as the tech giant increasingly looks to return cash to shareholders.The longest portion of the offering, a 40-year security, will yield 0.92 percentage points above Treasuries, according to a person familiar with the matter, who asked not to be identified as the details are private. Initial price discussions were in the 1.15 percentage points range.Proceeds from the sale will

  • Robinhood is now a public company: Morning Brief

    Top news and what to watch in the markets on Friday, July 30, 2021.

  • Buy These 2 New Stocks Before They Surge Over 50%, Says Oppenheimer

    We’re well into the Q2 earnings season and the results coming in show a strong overall performance so far. In fact, according to FactSet, if the S&P 500’s actual growth rate for the quarter hits 74.2% - as appears likely right now - it will amount to the biggest year-over-year earnings growth rate the index has displayed since Q4 2009. It’s a confidence boosting turn of events and a slightly surprising one, as noted by Oppenheimer’s Chief Investment Strategist John Stoltzfus. Stoltzfus believes

  • Robinhood Has the Worst Debut Ever for IPO of Its Size

    (Bloomberg) -- Robinhood Markets Inc. wanted to make history with its initial public offering, and now it has -- for the wrong reason.Shares in the broker behind the meme-stock revolution fell 8.4% below the IPO price in the company’s first trading session. That’s the worst debut on record among 51 U.S. firms that raised as much cash as Robinhood or more, according to data compiled by Bloomberg.It dethroned the 2007 IPO by another brokerage, MF Global Holdings Ltd., as the worst debut among qual

  • The Huge News That Sent Tellurian Stock Surging Today

    Shares of Tellurian (NASDAQ: TELL) surged more than 12% in afternoon trading today, before closing up about 9%, only to surge again in after-hours trading. The big news was about as important as it gets for the company: It announced a 10-year contract with Royal Dutch Shell (NYSE: RDS.A)(NYSE: RDS.B) for 3 million metric tons of liquefied natural gas per year. What makes this particular deal so important is that it fills up essentially all of the capacity Tellurian expects to get from the first two plants at its long-anticipated Driftwood LNG facility.

  • Amazon stock falls 7% as pandemic sales boom appears to stall

    Amazon.com Inc. sales growth slowed down in the second quarter of the year as bricks-and-mortar stores reopened across the U.S., sending shares south in after-hours trading Thursday.

  • This Is the Biggest Risk With Investing in Sundial Growers

    Canadian marijuana company Sundial Growers (NASDAQ: SNDL) is a much safer investment than it was at the start of the year. Initially, Sundial invested CA$188 million, and it has since increased that to CA$538 million.

  • Caterpillar net profit triples, revenue rises above forecasts even as construction industries came up shy

    Shares of Caterpillar Inc. edged up 0.2% in premarket trading, as the construction and mining equipment company reported a second-quarter net profit that tripled and revenue that topped forecasts, even as the largest construction business came up short. Net income rose to $1.41 billion, or $2.56 a share, from $458 million, or 84 cents a share, in the year-ago period. Excluding nonrecurring items, adjusted earnings per share rose to $2.60 from $1.27, beating the FactSet consensus of $2.41. Total

  • Chevron tops profit estimates, joins share buyback stampede

    (Reuters) -Chevron Corp on Friday reported its highest profit in six quarters and joined an oil industry stampede to reward investors with share buybacks, as rebounding crude oil prices carried earnings and cash flow to pre-pandemic levels. Oil and gas are trading near multi-year highs as fuel consumption has thrown off pandemic losses and natural gas has soared on weather demand. OPEC's decision to carry production curbs into next year has kept oil trading above $70 per barrel.

  • Why PayPal Stock Dropped Today

    What happened Shares of PayPal Holdings (NASDAQ: PYPL) fell 6.2% on Thursday, following the release of the digital payment giant's second-quarter results.  So what PayPal's net revenue jumped 19% year over year to $6.

  • GE Earnings Were Very, Very Good. What Wall Street Says About Its Stock Now.

    The company posted better-than-expected earnings results on Tuesday, but Wall Street appears more excited about the industrial conglomerate’s improving cash flow. In addition to beating estimates, GE (ticker: GE) raised its full-year free-cash-flow guidance for its industrial operations to a midpoint of $4.3 billion, $800 million higher than the previous midpoint. “GE’s ‘north star’ continues to be improving [free cash flow],” wrote RBC analyst Deane Dray in a note published Tuesday.

  • Crypto exchange Binance to wind down derivatives in Europe

    LONDON (Reuters) -Major cryptocurrency exchange Binance said on Friday it would wind down its futures and derivatives products offerings across Europe, the latest move by the platform as pressure grows from regulators across the world. With immediate effect, Binance users in Germany, Italy and the Netherlands would be unable to open new futures or derivatives products accounts, the exchange said in a statement on its website. Increasingly worried over consumer protection and the standard of anti-money laundering checks at crypto exchanges, a string of regulators across the world - including Britain, Germany, Hong Kong and Italy - have in recent weeks ratcheted up pressure on Binance, one of the world's largest exchanges by trading volumes.

  • 5 Best Chinese Stocks To Buy And Watch As Beijing Crackdowns Continue

    Hundreds of Chinese companies are listed on U.S. markets. But which are the best Chinese stocks to buy or watch right now? Weibo, Sohu, Nio, BYD Co. and Li Auto. China is the world's most-populous nation and the second-largest economy with a booming urban middle class and amazing entrepreneurial activity.

  • Top Dividend Stocks for August 2021

    These are the top dividend stocks in the Russell 1000 with the highest forward dividend yield for August.